Production (Stage)
Aethlon Medical, Inc.
AEMD
$1.18
-$0.045-3.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 10.43% | -37.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.43% | -37.47% | |||
| Operating Income | -10.43% | 37.47% | |||
| Income Before Tax | -256.45% | 37.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -256.45% | 37.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -256.45% | 37.48% | |||
| EBIT | -10.43% | 37.47% | |||
| EBITDA | -10.93% | 38.54% | |||
| EPS Basic | -242.25% | 37.60% | |||
| Normalized Basic EPS | -242.23% | 37.60% | |||
| EPS Diluted | -242.25% | 37.60% | |||
| Normalized Diluted EPS | -242.23% | 37.60% | |||
| Average Basic Shares Outstanding | 4.15% | 0.18% | |||
| Average Diluted Shares Outstanding | 4.15% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||